These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12798335)

  • 1. 6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2205-9. PubMed ID: 12798335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
    Rao PN; Uddin MJ; Knaus EE
    J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors.
    Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A
    Bioorg Med Chem Lett; 2003 Feb; 13(4):657-60. PubMed ID: 12639552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor.
    Leblanc Y; Roy P; Boyce S; Brideau C; Chan CC; Charleson S; Gordon R; Grimm E; Guay J; Léger S; Li CS; Riendeau D; Visco D; Wang Z; Webb J; Xu LJ; Prasit P
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2207-12. PubMed ID: 10465547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors.
    Park CH; Siomboing X; Yous S; Gressier B; Luyckx M; Chavatte P
    Eur J Med Chem; 2002 Jun; 37(6):461-8. PubMed ID: 12204472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of (E)- and (Z)-styryl-2-acetoxyphenyl sulfides and sulfones as cyclooxygenase-2 inhibitors.
    Reddy MV; Mallireddigari MR; Pallela VR; Venkatapuram P; Boominathan R; Bell SC; Reddy EP
    Bioorg Med Chem; 2005 Mar; 13(5):1715-23. PubMed ID: 15698789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of acyclic 2-alkyl-1,2-diaryl (E)-olefins as selective cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Rahim MA; McDonald R; Knaus EE
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4911-4. PubMed ID: 15341950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxygenase-2 inhibitors.
    Rahim MA; Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2753-6. PubMed ID: 12217369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors.
    Dubé D; Brideau C; Deschênes D; Fortin R; Friesen RW; Gordon R; Girard Y; Riendeau D; Savoie C; Chan CC
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1715-20. PubMed ID: 10397507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
    Srinath P; Rao PN; Knaus EE; Suresh MR
    Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atropisomeric myristinins: selective COX-2 inhibitors and antifungal agents from Myristica cinnamomea.
    Sawadjoon S; Kittakoop P; Kirtikara K; Vichai V; Tanticharoen M; Thebtaranonth Y
    J Org Chem; 2002 Aug; 67(16):5470-5. PubMed ID: 12153244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
    Zarghi A; Praveen Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors.
    Hyup YH; Kwan JK; Kang SH; Noh MS; Ha JY; Kyu JK; Min KM; Hoon CH; Chung S
    Bioorg Med Chem Lett; 2003 Feb; 13(3):413-7. PubMed ID: 12565941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile.
    Leblanc Y; Roy P; Wang Z; Li CS; Chauret N; Nicoll-Griffith DA; Silva JM; Aubin Y; Yergey JA; Chan CC; Riendeau D; Brideau C; Gordon R; Xu L; Webb J; Visco DM; Prasit P
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3317-20. PubMed ID: 12392741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase inhibitors derived from thalidomide.
    Suizu M; Muroya Y; Kakuta H; Kagechika H; Tanatani A; Nagasawa K; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1098-102. PubMed ID: 12951457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.